Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Parent Market Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America Topical Drugs CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advancements & growing R&D investments
3.2.1.2. Rising demand for topical medications
3.2.1.3. Expansion of manufacturing capacities and partnerships
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance with strict regulatory requirements
3.2.2.2. Limited efficacy in certain conditions limits the adoption of topical products
3.3. Pricing Analysis
3.4. Topical Drugs CDMO Capacity Outlook
3.4.1. CDMO Manufacturing Container Capacity
3.4.2. Topical Drugs Container Capacity By Product Type
3.5. North America Topical Drugs CDMO Market Outlook By Product Category
3.5.1. North America Topical Drugs CDMO Market Share, By Product Category, 2024 (%)
3.5.2. Prescription Drugs
3.5.2.1. Segment Overview
3.5.2.2. Major Prescription Drugs, By Product Type
3.5.3. Generic Drugs
3.5.3.1. Segment Overview
3.5.3.2. Major Generic Drugs, By Product Type
3.5.4. Over-the-counter (OTC) Drugs
3.5.4.1. Segment Overview
3.5.4.2. Major OTC Drugs, By Product Type
3.6. North America Topical Drugs CDMO Market Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
3.6.4. U.S. Tariff Impact Analysis
Chapter 4. North America Topical Drugs CDMO Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. North America Topical Drugs CDMO Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Semi-solid Formulations
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Creams
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Ointments
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Lotions
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Liquid Formulations
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Suspensions
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Solutions
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Solid Formulations
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Transdermal Products
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. North America Topical Drugs CDMO Market: Service Estimates & Trend Analysis
5.1. Service Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. North America Topical Drugs CDMO Market by Service Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Contract Development
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Formulation Development
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Analytical Testing
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. Stability Testing
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.5. Others
5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Contract Manufacturing
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Clinical
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Commercial
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. North America Topical Drugs CDMO Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. North America Topical Drugs CDMO Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Pharmaceutical Companies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Biopharmaceutical Companies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. North America Topical Drugs CDMO Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2024 & 2030
7.2. Country Market Dashboard
7.3. Country Market Snapshot
7.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030
7.5. U.S.
7.5.1. Key country dynamics
7.5.2. Competitive scenario
7.5.3. Regulatory framework
7.5.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Canada
7.6.1. Key country dynamics
7.6.2. Competitive scenario
7.6.3. Regulatory framework
7.6.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Mexico
7.7.1. Key country dynamics
7.7.2. Competitive scenario
7.7.3. Regulatory framework
7.7.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Company Market Share/Assessment Analysis, 2024
8.3. Company Profiles
8.3.1. The Lubrizol Corporation
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product/service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cambrex Corporation
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product/service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Contract Pharmaceuticals Limited
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product/service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Bora Pharmaceutical CDMO
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product/service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Ascendia Pharmaceuticals
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product/service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Pierre Fabre S.A.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product/service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Piramal Pharma Solutions
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product/service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. DPT Laboratories, LTD.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product/service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. MedPharm Ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product/service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Zenvisionpharma
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product/service benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global topical drugs CDMO: market estimates and forecasts, 2018-2030 (USD Billion)
Table 4 Global topical drugs: market estimates and forecasts, 2018-2030 (USD Billion)
Table 5 Development stages baseline model parameter estimates, By topical drugs
Table 6 Global topical drugs CDMO manufacturing container capacity/batch
Table 7 Global topical drugs capacity, by product type (per unit)
Table 8 Global topical drugs capacity, by container type (per unit)
Table 9 North America topical drugs CDMO market share, by product category, 2024 (%)
Table 10 List of major prescription drugs, by product type (2024)
Table 11 List of major generic drugs, by product type (2024)
Table 12 List of major OTC drugs, by product type (2024)
Table 13 North America topical drugs CDMO market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 14 North America topical drugs CDMO market estimates and forecasts, by semi-solid formulations, 2018-2030 (USD Million)
Table 15 North America topical drugs CDMO market estimates and forecasts, by liquid formulation drugs, 2018-2030 (USD Million)
Table 16 North America topical drugs CDMO market estimates and forecasts, by service, 2018-2030 (USD Million)
Table 17 North America topical drugs CDMO market estimates and forecasts, by contract development, 2018-2030 (USD Million)
Table 18 North America topical drugs CDMO market estimates and forecasts, by contract manufacturing, 2018-2030 (USD Million)
Table 19 North America topical drugs CDMO market estimates and forecasts, by end use, 2018-2030 (USD Million)
Table 20 North America topical drugs CDMO market estimates and forecasts, by country, 2018-2030 (USD Million)
Table 21 U.S. topical drugs CDMO market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 22 U.S. topical drugs CDMO market estimates and forecasts, by semi-solid formulations, 2018-2030 (USD Million)
Table 23 U.S. topical drugs CDMO market estimates and forecasts, by liquid formulation drugs, 2018-2030 (USD Million)
Table 24 U.S. topical drugs CDMO market estimates and forecasts, by service, 2018-2030 (USD Million)
Table 25 U.S. topical drugs CDMO market estimates and forecasts, by contract development, 2018-2030 (USD Million)
Table 26 U.S. topical drugs CDMO market estimates and forecasts, by contract manufacturing, 2018-2030 (USD Million)
Table 27 U.S. topical drugs CDMO market estimates and forecasts, by end use, 2018-2030 (USD Million)
Table 28 Canada topical drugs CDMO market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 29 Canada topical drugs CDMO market estimates and forecasts, by semi-solid formulations, 2018-2030 (USD Million)
Table 30 Canada topical drugs CDMO market estimates and forecasts, by liquid formulation drugs, 2018-2030 (USD Million)
Table 31 Canada topical drugs CDMO market estimates and forecasts, by service, 2018-2030 (USD Million)
Table 32 Canada topical drugs CDMO market estimates and forecasts, by contract development, 2018-2030 (USD Million)
Table 33 Canada topical drugs CDMO market estimates and forecasts, by contract manufacturing, 2018-2030 (USD Million)
Table 34 Canada topical drugs CDMO market estimates and forecasts, by end use, 2018-2030 (USD Million)
Table 35 Mexico topical drugs CDMO market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 36 Mexico topical drugs CDMO market estimates and forecasts, by semi-solid formulations, 2018-2030 (USD Million)
Table 37 Mexico topical drugs CDMO market estimates and forecasts, by liquid formulation drugs, 2018-2030 (USD Million)
Table 38 Mexico topical drugs CDMO market estimates and forecasts, by service, 2018-2030 (USD Million)
Table 39 Mexico topical drugs CDMO market estimates and forecasts, by contract development, 2018-2030 (USD Million)
Table 40 Mexico topical drugs CDMO market estimates and forecasts, by contract manufacturing, 2018-2030 (USD Million)
Table 41 Mexico topical drugs CDMO market estimates and forecasts, by end use, 2018-2030 (USD Million)
Table 42 Company profiles: Company overview
Table 43 Company profiles: Financial performance
Table 44 Company profiles: Service benchmarking
Table 45 Key company initiating service launches/upgrades
Table 46 Key companies initiating mergers/acquisitions/joint ventures
Table 47 Key companies initiating partnerships
Table 48 Key companies initiating expansion
Table 49 Key companies initiating others
List of Figures
Figure 1 North America topical drugs CDMO market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Commodity flow analysis
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Global topical drugs CDMO market outlook, 2023 (USD Billion)
Figure 13 Global topical drugs market outlook, 2023 (USD Billion)
Figure 14 North America topical drugs CDMO market dynamics
Figure 15 Porter’s Five Forces analysis
Figure 16 SWOT analysis, by factor (political & legal, economic and technological)
Figure 17 North America Topical Drugs CDMO market: Product Type outlook and key takeaways
Figure 18 North America Topical Drugs CDMO market: Product Type movement analysis
Figure 19 Semi-solid formulations market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Creams market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Ointments market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Lotions market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Liquid formulations market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Suspensions market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Solutions market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Solid formulations market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Transdermal products market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 North America Topical Drugs CDMO market: Service type outlook and key takeaways
Figure 30 North America Topical Drugs CDMO market: Service type movement analysis
Figure 31 Contract development market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Formulation development market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Analytical testing market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Stability testing market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Clinical market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Commercial market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 North America Topical Drugs CDMO market: sponsors outlook and key takeaways
Figure 40 North America Topical Drugs CDMO market: sponsors movement analysis
Figure 41 Pharmaceutical companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Biopharmaceutical companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 North America Topical Drugs CDMO market revenue, by country, 2023 & 2030 (USD Million)
Figure 45 Regional outlook, 2023 & 2030
Figure 46 Regional Market Share Analysis, 2023 & 2030
Figure 47 North America Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD million)
Figure 48 Key country dynamics
Figure 49 U.S. Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD million)
Figure 50 Key country dynamics
Figure 51 Canada Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD million)
Figure 52 Market participant categorization
Figure 53 Market participant categorization
Figure 54 Heat map analysis
